Lasa Supergenerics Ltd
company logo

Lasa Supergenerics Ltd

Lasa Supergeneri Share Price

Pharmaceuticals
Small Cap

-

0 (0%)


Start Investing in Lasa Supergenerics Ltd

*By signing up you agree to our Terms and Conditions

Lasa Supergenerics Ltd Performance

-

-

-

-


-

-

-

-

-

Lasa Supergenerics Ltd Fundamentals

137.98Cr

0

1.43

0.20

0

0%

19.30

i buttonClick here to know more about Fundamentals

Lasa Supergenerics Ltd Financials

Lasa Supergenerics Ltd Financialsright-arrow

Lasa Supergenerics Ltd Shareholding Pattern

Lasa Supergenerics Ltd Delivery and Volume

About Lasa Supergenerics Ltd

Lasa Supergenerics Limited was incorporated on March 11, 2016. The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire vet

Omkar P Herlekar

2016

LASA

NameDesignation
Omkar P HerlekarChairman & Managing Director
Shivanand HedgeWhole-time Director
Hardesh TolaniIndependent Director
Ajay SukhwaniIndependent Director
Ekta GurnasinghaniIndependent Director
Mitti M JainCompany Sec. & Compli. Officer
Manali BhagtaniIndependent Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Lasa Supergenerics Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Lasa Supergenerics Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Lasa Supergenerics Ltd's share price is ₹27.21 as of 2024-10-10.
Lasa Supergenerics Ltd's P/E ratio is - times as of 2024-10-10.
Lasa Supergenerics Ltd's most recent financial reports indicate a price-to-book ratio of 1.43, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Lasa Supergenerics Ltd's market capitalization is ₹137.98 Cr as on 2024-10-10.
The current financial records of Lasa Supergenerics Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Lasa Supergenerics Ltd's most recent financial filings, the company has a total asset value of ₹38.26, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Lasa Supergenerics Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Lasa Supergenerics Ltd's 52-week high and low as of 2024-10-10 are ₹28.8 and ₹27, respectively.